AGP Franklin LLC Takes $992,000 Position in Aflac Incorporated (NYSE:AFL)

AGP Franklin LLC acquired a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 9,592 shares of the financial services provider's stock, valued at approximately $992,000.

Other institutional investors have also bought and sold shares of the company. Guggenheim Capital LLC grew its holdings in Aflac by 4.7% during the fourth quarter. Guggenheim Capital LLC now owns 86,443 shares of the financial services provider's stock worth $8,942,000 after acquiring an additional 3,842 shares during the period. XTX Topco Ltd raised its holdings in shares of Aflac by 1,061.3% in the 4th quarter. XTX Topco Ltd now owns 40,380 shares of the financial services provider's stock worth $4,177,000 after purchasing an additional 36,903 shares in the last quarter. Hanlon Investment Management Inc. lifted its stake in Aflac by 16.9% during the fourth quarter. Hanlon Investment Management Inc. now owns 8,479 shares of the financial services provider's stock valued at $877,000 after purchasing an additional 1,224 shares during the last quarter. CreativeOne Wealth LLC lifted its stake in Aflac by 110.7% during the fourth quarter. CreativeOne Wealth LLC now owns 6,315 shares of the financial services provider's stock valued at $653,000 after purchasing an additional 3,318 shares during the last quarter. Finally, Mariner LLC grew its position in Aflac by 6.6% in the fourth quarter. Mariner LLC now owns 158,382 shares of the financial services provider's stock worth $16,383,000 after buying an additional 9,777 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company's stock.

Aflac Stock Up 0.0 %

Shares of AFL stock traded up $0.01 on Friday, hitting $107.35. 2,294,639 shares of the stock were exchanged, compared to its average volume of 2,125,455. The business has a 50-day moving average of $106.72 and a 200 day moving average of $107.28. Aflac Incorporated has a fifty-two week low of $80.59 and a fifty-two week high of $115.50. The firm has a market capitalization of $58.59 billion, a P/E ratio of 11.18, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Equities analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Insider Transactions at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the transaction, the director now owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the transaction, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on AFL. Barclays cut their price objective on Aflac from $98.00 to $95.00 and set an "underweight" rating on the stock in a report on Friday, February 7th. Wells Fargo & Company lowered their price objective on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 19th. Morgan Stanley reduced their target price on Aflac from $105.00 to $100.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. JPMorgan Chase & Co. lifted their price target on Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a report on Wednesday, April 2nd. Finally, Piper Sandler increased their price objective on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, Aflac currently has an average rating of "Hold" and a consensus price target of $103.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.